Tyson Foods, Inc. (NYSE: TSN) has struggled in recent years as falling protein prices, high feed costs, and weaker export demand pressured earnings. The stock now trades near $52/share, down from about $60/share a year ago.
Recently, Tyson reported fiscal Q3 2025 results that showed early signs of recovery. Operating income improved across its Chicken and Prepared Foods segments, while the Beef segment returned to profitability after several quarters of losses. Management also announced new automation and supply chain initiatives aimed at improving efficiency and reducing long-term costs. These moves suggest Tyson is steadily regaining control over its operations despite a challenging protein market.
This article explores where Wall Street analysts think Tyson Foods could trade by 2027. We’ve pulled together consensus price targets and valuation models from TIKR to outline the stock’s potential path based on current expectations, not TIKR’s own forecasts.
Unlock our Free Report: 5 AI compounders that analysts believe are undervalued and could deliver years of outperformance with accelerating AI adoption (Sign up for TIKR, it’s free) >>>
Analyst Price Targets Suggest Modest Upside
Tyson Foods trades at about $52/share today. The average analyst price target is $63/share, which points to roughly 20% upside over the next 12 months. Forecasts remain fairly tight, showing moderate conviction across Wall Street:
- High estimate: ~$80/share
- Low estimate: ~$55/share
- Median target: ~$60/share
- Ratings: 3 Buys, 1 Outperform, 10 Holds, 1 Sell
For investors, that signals a modest upside scenario. Analysts see gradual progress as Tyson rebuilds profitability, but sentiment remains cautious. The market appears to be waiting for more evidence that cost savings and operational changes will translate into stronger earnings growth.
See analysts’ growth forecasts and price targets for Tyson Foods (It’s free!) >>>
Tyson Foods: Growth Outlook and Valuation
Tyson’s fundamentals are slowly improving after a difficult period for the protein industry:
- Revenue is projected to grow about 2% annually through 2027
- Operating margins are expected to rise toward 4%, still below pre-2021 levels
- Shares trade near 14x forward earnings, slightly below their five-year average of 15x
- Based on analysts’ average estimates, TIKR’s Guided Valuation Model using a 14x forward P/E suggests Tyson could trade around $68/share by 2027
- That represents about 31% total upside, or roughly 14% annualized returns
For investors, this points to a meaningful longer-term opportunity if Tyson executes well. The company looks reasonably valued today, and improving efficiency, better balance in protein pricing, and continued brand strength could help earnings recover.
Value stocks like Tyson Foods in as little as 60 seconds with TIKR (It’s free) >>>
What’s Driving the Optimism?
Tyson’s fundamentals are showing early signs of recovery. The company has tightened cost control, improved pricing discipline, and shifted focus toward higher-margin prepared foods. Its Prepared Foods and Chicken divisions are regaining profitability as automation and restructuring efforts take effect.
Management has also taken a more disciplined approach to capacity, reducing oversupply that weighed on margins in recent years. As global protein demand normalizes and inflation pressures ease, Tyson’s balance sheet should strengthen further.
For investors, these steps suggest Tyson is on the right path. It may not be back to peak performance yet, but the company is positioned for gradual improvement in earnings quality and cash flow stability.
Bear Case: Margin Pressure and Demand Risk
Even with visible progress, Tyson’s recovery remains fragile. Protein pricing can swing sharply with commodity cycles, and export demand from Asia remains inconsistent. Input costs for feed and logistics are another wildcard that could limit margin expansion.
Competition also remains intense, especially from lower-cost producers and private-label brands. For investors, this means profitability may stay volatile. If margin gains stall or global protein supply outpaces demand again, Tyson could struggle to meet even moderate growth expectations.
Outlook for 2027: What Could Tyson Be Worth?
Based on analysts’ average estimates, TIKR’s Guided Valuation Model using a 14x forward P/E suggests Tyson could trade near $68/share by 2027. That represents about 31% total upside, or roughly 14% annualized returns from current levels.
This projection assumes steady revenue growth, modest margin recovery, and continued cost discipline. It reflects a reasonable, not overly optimistic, path for improvement.
For investors, Tyson looks like a measured turnaround play rather than a high-growth story. The setup favors patient investors who can look past short-term volatility and focus on long-term execution. With improving fundamentals and a healthy dividend, Tyson could quietly deliver solid total returns as its efficiency gains compound.
AI Compounders With Massive Upside That Wall Street Is Overlooking
Everyone wants to cash in on AI. But while the crowd chases the obvious names benefiting from AI like NVIDIA, AMD, or Taiwan Semiconductor, the real opportunity may lie on the AI application layer where a handful of compounders are quietly embedding AI into products people already use every day.
TIKR just released a new free report on 5 undervalued compounders that analysts believe could deliver years of outperformance as AI adoption accelerates.
Inside the report, you’ll find:
- Businesses already turning AI into revenue and earnings growth
- Stocks trading below fair value despite strong analyst forecasts
- Unique picks most investors haven’t even considered
If you want to catch the next wave of AI winners, this report is a must-read.
Click here to sign up for TIKR and get your free copy of TIKR’s 5 AI Compounders report today.